Item 5. Market for Registrant’s Common Equity
Item
5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market
Information
Our
common stock has been quoted through various over-the-counter quotation systems at various times since 2009. Our common stock currently
trades on the OTC Markets under the symbol “MLCT.”
The
following table sets forth the range of reported high and low closing bid quotations for our common stock for the fiscal quarters indicated
as reported by OTC Markets Group. Common stock price reflects inter-dealer quotations, does not include retail markups, markdowns or
commissions and does not necessarily represent actual transactions.
High
Low
Nine
Months Ended December 31, 2021
First
Quarter ended June 30, 2021
$ 0.50
$ 0.13
Second Quarter ended
September 30, 2021
0.85
0.14
Third Quarter ended
December 31, 2021
0.50
0.22
Fiscal
Year Ended December 31, 2022
First
Quarter ended March 31, 2022
$ 0.37
$ 0.13
Second Quarter ended
June 30, 2022
0.25
0.12
Third Quarter ended
September 30, 2022
0.20
0.13
Fourth Quarter ended
December 31, 2022
0.21
0.13
Transfer
Agent
The
transfer agent and registrar for our common stock is Securities Transfer Corporation, 2901 North Dallas Parkway, Suite 380, Plano, Texas
75093.
Holders
of Common Stock
As
of March 30, 2023, there were 74 holders of record of our common stock.
Dividends
We
have never declared or paid any cash dividends or distributions on our common stock. We currently intend to retain our future earnings,
if any, to support operations and to finance expansion and we do not anticipate paying any cash dividends on our common stock in the
foreseeable future.
Equity
Compensation Plan Information
During
the year ended December 31, 2022, we issued options to purchase 2,650,000 shares of the Company’s common stock under the Malachite
Innovations, Inc. 2021 Stock Incentive Plan. Except as listed in the table below, as of December 31, 2022, we do not have any equity-based
plans, including individual compensation arrangements, which have not been approved by our stockholders.
40
The
following table provides information as of December 31, 2022 with respect to our equity compensation plans:
Equity
Compensation Plan Information
Plan
Category
Number
of
securities
to be
issued
upon
exercise
of
outstanding
options,
warrants
and
rights
Weighted-
average
exercise
price
of
outstanding
options,
warrants
and
rights
Number
of
securities
remaining
available
for
future
issuance
under
equity
compensation
plans
(excluding
securities
reflected
in
column
(a))
(a)
(b)
(c)
Equity
compensation plans approved by security holders
9,392,544
$ 0.54
6,200,000
Total
9,392,544
$ 0.54
6,200,000
Item
6. Selected Financial Data
Not
applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.